Role of Nalpamaradi kera taila in prevention of garbhini kikkisa
Not Applicable
- Conditions
- Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2023/08/056916
- Lead Sponsor
- Dr Bobade Kiran Pralhad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Primi Gravida will be taken for the study
Exclusion Criteria
Multi gravida
Previous surgical scar on abdomen
Pre existing skin disease
Obesity
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method By use of this taila, we will be assessing the symptoms like kandu, daha, vaivarnyata and location of straie according to the Daveys scoring patternTimepoint: Assessment of the condition will be done from 25th week till 36th week
- Secondary Outcome Measures
Name Time Method Taila is used for prevention of daha kandu & vaivarnyata which are the primary symptoms of the kikkisaTimepoint: It is used from 2nd trimester till term & assessment will be done from 25th week till 36th week of gestation
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Nalpamaradi kera taila's effects on skin elasticity during pregnancy?
How does Nalpamaradi kera taila compare to standard-of-care treatments for striae gravidarum in clinical efficacy?
Are there specific biomarkers that predict response to Nalpamaradi kera taila in preventing striae gravidarum?
What are the potential adverse events associated with Nalpamaradi kera taila use in pregnant women and how are they managed?
What related compounds or combination therapies are being explored for the prevention of striae gravidarum in pregnancy?